The federal government has widened its probe of prescription drug maker Johnson & Johnson for its marketing practices. Specifically, the company is coming under further scrutiny for its antipsychotic Risperdal; Topamax, a treatment for epilepsy and migraines; and Natrecor, for patients suffering from severe heart failure.
Government Probes J&J Prescription Drug Marketing Practices
The federal government has widened its probe of prescription drug maker Johnson & Johnson for its marketing practices. Specifically, the company is coming under further scrutiny for its antipsychotic Risperdal; Topamax, a treatment for epilepsy and migraines; and Natrecor, for patients suffering fro
Published:
Last updated:
The Legal Examiner
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
All articles
Tags:
Legal
More in Legal
See all
